E0 ConsensusPreliminaryPEM unclearReview-NarrativePeer-reviewedReviewed
A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?
Navaneetharaja, Navena, Griffiths, Verity, Wileman, Tom et al. · Journal of clinical medicine · 2016 · DOI
Quick Summary
This review examines whether infections—particularly viruses in the gut—might trigger ME/CFS. The authors suggest that an imbalance in the gut's microbial and viral communities could be a key factor in developing the disease. They propose that understanding these gut infections could help identify better treatments and ways to prevent ME/CFS.
Why It Matters
This review shifts focus toward the gut microbiota and virome as potential disease drivers in ME/CFS, offering a testable mechanism that could explain immune dysfunction and guide development of microbiota-targeted therapeutics. Identifying the 'infectious trigger' could provide diagnostic biomarkers urgently needed for ME/CFS research and clinical management.
Observed Findings
- Immune-related symptoms of moderate-to-severe severity persist long-term in ME/CFS patients, consistent with chronic inflammatory or autoimmune processes
- B cell depletion therapy shows therapeutic benefit, indicating B cell involvement in disease pathogenesis
- Evidence of acute or chronic viral infections has been identified in ME/CFS populations, though causality remains unclear
- Both host and environmental factors are proposed to contribute to ME/CFS heterogeneity
Inferred Conclusions
- The intestinal microbiota and virome, rather than systemic pathogens, may represent the primary infectious trigger for ME/CFS
- Dysbiosis-mediated breakdown of intestinal barrier function could precipitate autoimmune activation and B cell dysfunction in susceptible individuals
- Identifying specific microbial or viral signatures could enable biomarker-driven diagnosis and microbiota-targeted interventions
- Understanding the microbiota-virome axis is essential to developing disease prevention and management strategies
Remaining Questions
- Does dysbiosis precede ME/CFS onset, or does it develop secondary to illness? Which specific microorganisms or viral taxa drive pathogenic immune responses?
- How do genetic and environmental factors determine susceptibility to microbiota-induced autoimmunity in ME/CFS?
What This Study Does Not Prove
This review does not establish causation—it synthesizes existing evidence to propose a hypothesis rather than proving that microbiota or virome changes directly cause ME/CFS. The proposal remains conceptual and requires prospective, mechanistic studies to confirm whether dysbiosis precedes disease onset or develops as a consequence of illness.
Tags
Symptom:Fatigue
Phenotype:Infection-Triggered
Method Flag:Exploratory OnlyPEM Not DefinedWeak Case Definition
Biomarker:CytokinesAutoantibodies
Metadata
- DOI
- 10.3390/jcm5060055
- PMID
- 27275835
- Review status
- Editor reviewed
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.